Psychopharmacists' role in neuroleptic therapy. A pharmaceutical care approach.
OBJECTIVE
To describe the roles of the psychopharmacist in the use of neuroleptic therapy.


METHODS
A geriatric psychiatry ambulatory care clinic in a 400-bed Department of Veterans Affairs Medical Center, San Diego, California.


CONCLUSIONS
In the pharmaceutical care model, the pharmacist is involved in several important roles in the provision of neuroleptic therapy. In the ambulatory care program, psychopharmacists provide important drug-related information to patients and consultation regarding potential neuroleptic-induced adverse effects. In addition, psychopharmacists serve as consultants to other clinicians concerning the risks associated with the use of neuroleptics and participate in neuroleptic-discontinuation clinics. Morbidity associated with neuroleptic-induced tardive dyskinesia has exposed healthcare providers to legal repercussions; therefore, pharmacy intervention may aid in the reduction of legal liability.
Veteran Affairs Medical Center, San Diego, CA 92161.
J P
JP
Lacro
A B
AB
Kodsi
P L
PL
Gilbert
D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002140:California; D016903:Drug Monitoring / Q000379:methods*; D004409:Dyskinesia, Drug-Induced / Q000517:prevention & control*; D005568:Forms and Records Control; D006745:Hospital Bed Capacity, 300 to 499; D006787:Hospitals, Veterans; D006801:Humans; D007258:Informed Consent; D010044:Outpatient Clinics, Hospital; D010348:Patient Care Team; D010353:Patient Education as Topic; D010607:Pharmacy Service, Hospital / Q000592:standards*; D011569:Psychiatric Status Rating Scales; D012380:Role